Actual Medicinal Product (AMP) Cefaclor 375mg modified-release tablets (Sun Pharma UK Ltd)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability: Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: Light sensitive medicine. Store in light resistant container.   No stability data in MCAs available.
Provenance: This recommendation is based on the products Distaclor 375mg modified release tablets (Flynn Pharma Ltd) and Cefaclor 375mg modified release tablets (Flynn Pharma Ltd).
Generic: Cefaclor
Formulation: Cefaclor 375mg modified-release tablets